Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 11 - 20 out of 255

Friends of AHRQ Coalition Urges Robust FY27 Funding

March 2, 2026

AMIA joined the Friends of AHRQ coalition in signing a March 2, 2026, letter to Congressional appropriators urging at least $500 million in funding for the Agency for Healthcare Research and Quality (AHRQ) for fiscal year 2027. The letter highlights AHRQ’s essential role in health services and primary care research […]

DOE Reimagining and Improving Student Education Proposed Rule

March 2, 2026

AMIA submitted comments opposing aspects of the Reimagining and Improving Student Education proposed rule from the Department of Education (DOE). We argued nursing degrees (MSN/DNP) must remain professionally designated, as changes would raise financial barriers, worsen workforce shortages, and conflict with national health and informatics priorities. Maintaining professional nursing education […]

AMIA Supports JPHIT Response on ASTP/ONC’s HTI-5 Proposed Rule

February 27, 2026

AMIA signed on to support the Joint Public Health Informatics Taskforce (JPHIT) response to the Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI‑5) Proposed Rule. AMIA endorsed JPHIT’s recommendations to ensure that updates to the ONC Health IT Certification Program maintain strong support for public health […]

ASTP/ONC HTI-5 Proposed Rule

February 26, 2026

AMIA supports the goals of the HTI-5 proposed rule to reduce burden, strengthen interoperability, and expand patient access through standards-based APIs. However, we caution that removing numerous certification criteria, particularly those related to privacy, security, and AI transparency, could introduce unintended risks. We urge clearer safeguards, phased implementation, equity protections […]

HHS RFI Accelerate AI in Clinical Care

February 23, 2026

AMIA urges the U.S. Department of Health and Human Services to advance a risk-based, evidence-driven framework to support responsible AI adoption in clinical care. Key barriers include limited access to representative data, insufficient infrastructure, unclear return on investment, workforce readiness gaps, and weak governance structures. We recommend transparent oversight aligned […]

25x5 Recommendations to Reform Prior Authorization

January 21, 2026

It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]

AMIA Letter to Congress: Pass the Improving Seniors’ Timely Access to Care Act

January 21, 2026

It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]

AMIA Joins Coalition in Urging Robust FY26 NIH Funding

January 20, 2026

A broad coalition of patient, scientific, and medical organizations urges Congress to swiftly pass a full-year FY2026 appropriations bill funding NIH at $48.7 billion. The letter warns that continuing resolutions and shutdowns delay grants, threaten jobs, and undermine lifesaving research, while supporting Senate provisions on multiyear grants and facilities and […]

AMIA Comments on FDA Real-World Performance Monitoring and Equity Assessment of AI-Enabled Medical Devices

December 1, 2025

AMIA commented on FDA's request for public comment regarding real-world performance evaluation of AI-enabled medical devices. We support lifecycle governance with continuous post-market monitoring to address performance drift across diverse populations and settings. AMIA recommends comprehensive metrics beyond accuracy including clinical outcomes, safety, usability, and equity assessment. We emphasize transparent […]

AMIA Joins Request for Long-Term Fix to Medicare Telehealth

November 4, 2025

As one of 450 stakeholders, AMIA calls on Congress for permanent Medicare telehealth legislation. The current lapse affects 4+ million beneficiaries and 30% of providers delivering virtual care, disrupting healthcare innovation and informatics infrastructure. Temporary extensions create instability impeding technology adoption and evidence-based implementation. AMIA supports retroactive payment restoration and […]